#BioLargo Initiates Testing of Innovative Water Test Kit
BioLargo, Inc., based in Westminster, California, has launched alpha testing of a cutting-edge portable water test kit designed to detect per- and polyfluoroalkyl substances (PFAS). This kit, developed by Verralize, Inc., aims to provide rapid on-site testing, thereby streamlining how water treatment operators handle contamination issues.
The Verralize test kit is significant for its ability to deliver immediate results on-site, reducing the reliance on traditional laboratory methods that can delay response times. This innovation addresses the urgent need for efficient solutions in light of increasing regulatory scrutiny under the U.S. Safe Drinking Water Act, which seeks to manage the risks associated with "forever chemicals" like PFAS.
The alpha testing is set to take place at BioLargo's laboratory in Oak Ridge, Tennessee. It will be conducted using contaminated water samples supplied by clients, allowing the effectiveness and reliability of the kits to be assessed in practical settings.
With emphasis on user-friendliness and cost-effectiveness, the test kit distinguishes between various PFAS compounds. This capability enables water treatment operators to make informed decisions quickly, enhancing system performance and public health safety.
Pending successful validation, BioLargo plans to incorporate the test kit into its PFAS treatment services. This strategy is poised to not only provide a faster and more cost-efficient approach to monitoring pollution levels but also to position BioLargo favorably within the environmental technology landscape.
Both BioLargo and Verralize intend to present their innovative PFAS solutions, including the new test kit, at the Water Environment Federation's upcoming WEFTEC 2025 conference in September. This event will offer an opportunity to engage with industry stakeholders and showcase their advancements in public health and environmental solutions.
BioLargo's new PFAS test kit, developed by Verralize, enables rapid, on-site detection of PFAS contaminants in water. This is significant as it allows water treatment operators to respond more swiftly to contamination issues, potentially enhancing public safety and operational efficiency.
Unlike traditional lab-based testing methods that can be time-consuming and costly, the portable PFAS test kit offers immediate results on-site. This capability not only reduces delays but also empowers operators to make informed decisions without the lengthy wait often associated with lab analyses.
The alpha testing phase aims to validate the performance and commercial viability of the test kit before launching it on a broader scale. Successful validation will enable BioLargo to further integrate this technology into its PFAS treatment offerings, potentially enhancing the overall efficacy of their solutions.
The introduction of this test kit is likely to enhance the performance of BioLargo's PFAS treatment technologies. By providing quicker data on contamination levels, treatment operators can optimise their methods and improve system efficiencies.
BioLargo plans to showcase the test kit at the Water Environment Federation's WEFTEC 2025 conference this September. This event offers a valuable opportunity to present their innovative solutions to a wide audience, potentially attracting interest from clients and partners.
This test kit advances public health initiatives by providing timely results that help protect communities from PFAS contamination. Moreover, its accessibility aids in promoting environmental sustainability, particularly in underserved regions that are often most affected by water quality issues.
BioLargo's established nationwide network of manufacturer's sales representatives will play a crucial role in the distribution of the test kits. This infrastructure is expected to enhance accessibility, allowing a wider reach and more efficient delivery of this innovative product to end-users.
Beyond water testing, Verralize is exploring potential applications in biomarker discovery and clinical research. This extension into biotech showcases the versatility of the testing technology and highlights its growth potential across various sectors.